Citation: Chunyu Yan, Qinglong Qiao, Wei Zhou, Xuelian Zhou, Yonghui Chen, Lu Miao, Zhaochao Xu. FRET-based in vitro assay for rapid detecting of SARS-CoV-2 entry inhibitors[J]. Chinese Chemical Letters, ;2025, 36(5): 110258. doi: 10.1016/j.cclet.2024.110258 shu

FRET-based in vitro assay for rapid detecting of SARS-CoV-2 entry inhibitors

    * Corresponding authors.
    E-mail addresses: miaolu@dicp.ac.cn (L. Miao), zcxu@dicp.ac.cn (Z. Xu).
  • Received Date: 7 June 2024
    Revised Date: 12 July 2024
    Accepted Date: 15 July 2024
    Available Online: 15 July 2024

Figures(5)

  • The continuous mutation and rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have led to the ineffectiveness of many antiviral drugs targeting the original strain. To keep pace with the virus' evolutionary speed, there is a crucial need for the development of rapid, cost-effective, and efficient inhibitor screening methods. In this study, we created a novel approach based on fluorescence resonance energy transfer (FRET) technology for in vitro detection of inhibitors targeting the interaction between the SARS-CoV-2 spike protein RBD (s-RBD) and the virus receptor angiotensin-converting enzyme 2 (ACE2). Utilizing crystallographic insights into the s-RBD/ACE2 interaction, we modified ACE2 by fusing SNAP tag to its N-terminus (resulting in SA740) and Halo tag to s-RBD’s C-terminus (producing R525H and R541H), thereby ensuring the proximity (< 10 nm) of labeled FRET dyes. We found that relative to the R541H fusion protein, R525H exhibited higher FRET efficiency, which attributed to the shortened distance between FRET dyes due to the truncation of s-RBD. Utilizing the sensitive FRET effect between SA740 and R525H, we evaluated its efficacy in detecting inhibitors of SARS-CoV-2 entry in solution and live cells. Ultimately, this FRET-based detection method was demonstrated high sensitivity, rapidity, and simplicity in solution and held promise for high-throughput screening of SARS-CoV-2 inhibitors.
  • As the next generation of solid-state lighting diodes, white LEDs are believed to trigger a lighting revolution. LEDs have many distinct advantages over traditional incandescent and halogen lamps, such as energy savings, long life, and high efficiency [1-3]. There are many potential applications for white LEDs, such as everyday lighting, LCD backlights, and displays, so white LEDs have received widespread attention in recent years [4, 5]. The earliest commercializedwhite LEDs were developed by Nichia Corporation of Japan using blue light from GaN-based LED chips to excite rare earth phosphor YAG:Ce3+ to emit yellow light and combine it into white light [6-8]. However, such a white LED lacks a spectrum of a red light region, resulting in a poor color rendering index and low luminous efficiency. At present, the use of near-ultraviolet chips to excite trichromatic phosphors to achieve white light production has become the focus of currentwhite LEDs industry development [9-11]. This method overcomes the shortcomings of high color temperature and low color rendering index of "yellow-blue" combined white LED. Lumen efficiency and color reproduction performance are greatly affected by problems such as color resorption and ratio adjustment between multi-component phosphors [12]. Therefore, it has become a top priority to develop a new type of phosphor that can overcome the deficiency of mixed phosphors and improve luminescence property.

    Up to date, a method of adjusting white light generated by energy transfer (ET) between a sensitizer and an activator has been obtained in a single matrix phosphor, such as Sr3NaLa(PO4)3F:Eu2+, Mn2+ [13], Ca4(PO4)2O:Dy3+, Eu2+ [14], and Ca3YNa(PO4)3:Ce3+, Mn2+ [15]. From the standpoint of the reaction conditions, these reactions need to be carried out strictly under a reducing gas (N2/H2). However, single-component phosphors synthesized in the reaction air will be more promising. Due to the transition from Dy3+ 4F9/2 level to 6H13/2 and 6H15/2, Dy3+ ions can produce strong blue and yellow emission bands with peaks at 483 and 574 nm [16, 17]. White light can be produced by appropriately combining the two kinds of light. However, in most cases, the yellow emission of Dy3+ is stronger than the blue emission, resulting in yellowwhite light by single-doped Dy3+ ions. To overcome this problem, Tm3+ ion is introduced because it produces blue emission due to 1D2-3F4 transition (about 453 nm) [18, 19]. There are some reports on such white phosphors, such as, BaLaGa3O7:Tm3+, Dy3+ [20], YAl3(BO3)4: Tm3+, Dy3+ [21], and BaWO4:Tm3+, Dy3+ [22]. Therefore, by simultaneously doping Tm3+ and Dy3+ ions into a single host, a white light of a suitable yellow-blue intensity ratio can be obtained.

    Apatite refers to a group of minerals represented by calcium phosphate. Its crystal chemical formula is M5[XO4]3Z, where M is a +1, +2 and +3 valence metal; XO4 is a variety of acid ions; Z is an additional anions F-, Cl-, (OH)-, O2-, and so on. The apatite crystal belongs to the hexagonal system, P63/m, and the unit cell is Z = 2 [23, 24]. Hence, the apatite structure is an extraordinary structural model for designing high quality new phosphors. In this work, a series of single host white-emitting Ba3LaNa(PO4)3F:Tm3+, Dy3+ phosphors were prepared and their luminescence properties were investigated in detail. The results show that this strong coloradjustable BLNPF:Tm3+, Dy3+ phosphor has great potential as a UVpumped white LED.

    Tm3+, Dy3+ co-doped Ba3LaNa(PO4)3F phosphor was prepared by high temperature solid phase method. Based on the preparation of 1 g of the target product, BaCO3, La2O3, NH4H2PO4, Na2CO3, BaF2, Tm2O3, and Dy2O3 were weighed according to a molar ratio of 3:(1- x-y)/2:1/2:3:1/2:1/2: x: y. The above raw materials were placed in a mortar and thoroughly ground, and the mixture was placed in an alumina crucible and placed in a high temperature tube furnace. The temperature was raised from room temperature to 1050 ℃ at a heating rate of 10 ℃/min, and kept at 1050 ℃ for 3 h. After being naturally cooled to room temperature, it is sufficiently ground with a mortar to obtain Ba3LaNa(PO4)3F:Tm3+, Dy3+ phosphor, and the next step is characterized.

    Phase structure analysis was performed by a Bruker D2 X-ray diffractometer (XRD) using an X-ray source of Cu-K α ( λ = 1.5406 Å), a scan current of 10 mA, a scan voltage of 30 kV, and a scan rate of 0.08×/s, scan range is20×±80×. The excitation and emission spectra were measured using a Hitachi F-4600 fluorescence spectrometer with a 150 W xenon lamp with a slit width of 5 nm and a test voltage of 400 V. The instrument used for fluorescence decay lifetime was a FluoroLog-3 fluorescence spectrometer (HORIBA, France) using a Specral-LED (N-370) with a pulse width of 12 ns. All tests were performed at room temperature.

    XRD patterns of the as-prepared phosphors were collected to verify the phase purity. Fig. 1 shows the XRD patterns of Ba3LaNa(PO4)3F, Ba3La0.975Na(PO4)3F:0.025Tm3+, Ba3La0.960Na (PO4)3F:0.040Dy3+, and Ba3La0.945Na(PO4)3F:0.025Tm3+, 0.030Dy3+ phosphors. It is clear that according to JCPDS documents 71–1317, all diffraction peaks of these samples can be accurately assigned to the pure hexagonal phase of Ba3LaNa(PO4)3F. The map shows that no significant changes in crystal structure caused by other phases or impurities were detected, demonstrating that Tm3+ and Dy3+ ions successfully entered the Ba3LaNa(PO4)3F host [25]. In Ba3LaNa(PO4)3F host, Tm3+ and Dy3+ substitute La3+ sites because of the similar ionic radii.

    Figure 1

    Figure 1.  XRD patterns of (a) Ba3LaNa(PO4)3F; (b) Ba3La0.975Na(PO4)3F:0.025Tm3+; (c) Ba3La0.960Na(PO4)3F:0.040Dy3+; (d) Ba3La0.945Na(PO4)3F:0.025Tm3+, 0.030Dy3+ and the standard data Ba3LaNa(PO4)3F (JCPDS No. 71-1317) as a reference.

    The relationship between the emission intensity of Tm3+ and its doping concentration is shown in Fig. S1 (Supporting information). Meanwhile, in the emission wavelength range of 400–550 nm, the main emission peak of Tm3+ is located at 453 nm, which belongs to the transition of 1D2-3H6. The phosphor exhibits a strong blue emission, revealing its potential value in blue-emitting LED applications. Moreover, another relatively weak blue emission was observed due to the 1G4-3H6 transition of the Tm3+ ions [26]. As the concentration of Tm3+ ions increases, the emission intensity is positively correlated with the ion concentration until the maximum value is reached at x = 0.025, and concentration quenching occurs.

    Fig. S2 (Supporting information) demonstrated the emission and excitation spectra of Tm3+ and Dy3+ single doped and Tm3+/Dy3+ co-doped Ba3LaNa(PO4)3F phosphors. Fig. S2a displays the PL and PLE spectra of the Ba3La0.975Na(PO4)3F:0.025Tm3+ phosphor. The PLE spectrum monitored at 453 nm exhibited one peak centered at 358 nm corresponding to the transition from the 3H6 ground state to the 1D2 excited state of Tm3+. The band emission spectral characteristic has been discussed above. Fig. S2b shows the PLE and PL emission spectra of the Ba3La0.960Na (PO4)3F:0.040Dy3+ phosphor. The excitation spectrum consists of a series of sharp bands centered around 325, 350, 363, 387, 426, 452 and 477 nm, which are attributed to the 4f-4f transitions of Dy3+ ions from the ground state of 6H15/2 to the excited states of 4M17/2, 9P7/2, 4P5/2, 4I13/2, 4G11/2, 4I15/2 and 4F9/2, respectively [27]. It was clear that three main peaks located at 480 nm (4F9/2-6H15/2), 573 nm (4F9/2-6H13/2), and 663 nm (4F9/2-6H11/2) [28]. To further confirm the possible energy transfer process, Fig. S2c illustrates the PLE and PL spectra of Ba3La0.945Na(PO4)3F:0.025Tm3+, 0.030Dy3+ phosphor. A notable spectral overlap between the PLE spectrum of Ba3La0.960Na(PO4)3F:0.040Dy3+ and the PL spectrum Ba3La0.975Na- (PO4)3F:0.025Tm3+ is observed. So that the energy transfer from Tm3+ and Dy3+ ions can be achieved in the Ba3LaNa(PO4)3F host.

    By changing the relative concentrations of co-doped Tm3+ and Dy3+, the energy transfer process between Tm3+→Dy3+ ions can be further studied. It can be seen from Fig. 2 that the emission spectrum after co-doping is composed of Tm3+ and Dy3+, and the emission intensity of Tm3+ is significantly reduced as the Dy3+ doping concentration increases. This is due to the continuously enhanced energy transfer process between Tm3+ and Dy3+. Later, due to the concentration quenching between Dy3+ and Dy3+, the Dy3+ emission peak intensity increases first and then decreases and reaches a maximum at y = 0.030.

    Figure 2

    Figure 2.  Dependence of the PL spectra of Ba3La0.975-yNa(PO4)3F:0.025Tm3+, yDy3+ samples on the Dy3+ concentrations. The inset shows the relative intensity of Tm3+ (453 nm) and Dy3+ (573 nm) ions emission as a function of the doped content of Dy3+ ions.

    In order to further verify the energy transfer from Tm3+ and Dy3+, we synthesize a series of samples Ba3LaNa(PO4)3F: xTm3+, 0.040Dy3+. Fig. S3 (Supporting information) shows the PL spectra of Ba3LaNa(PO4)F: xTm3+, 0.040Dy3+. The inset shows the emission intensity trends of Tm3+ (453 nm) and Dy3+ (573 nm). At 350 nm excitation, the shape of the PL spectrum is very similar to the 0.025Tm3+, yDy3+ sample. It is apparent from the inset that as the Tm3+ doping concentration increases, the emission intensity at 453 nm gradually increases. However, the intensity of luminescence at Dy3+ (573 nm) increased firstly, reached its maximum when x = 0.015, then decrease.

    Fig. 3 illustrates the energy level model of the energy transfer process between Tm3+-Dy3+ in the BLNPF host. When Ba3LaNa (PO4)3F:Tm3+, Dy3+ phosphor is excited by 358 nm, the ground state electron (6H15/2) of Dy3+ ion is pumped to the excited state 4I11/2 state by energy transfer from Tm3+ ion. This is due to the difference between the similar energy gaps of the two ions of Tm3+ (1D2-3F4) and Dy3+ (6H15/2-4I15/2). Radiation transitions from 4F9/2 to 6H15/2, 6H13/2, and 6H11/2 can cause the emission main peaks to be centered at 480, 573, and 663 nm, respectively.

    Figure 3

    Figure 3.  Energy level scheme of Ba3LaNa(PO4)3F:Tm3+, Dy3+phospor with electronic transitions and energy transfer process.

    By changing the relative intensities of co-doped Tm3+/Dy3+ ions, the formula for calculating the energy transfer efficiency ( ηET) of Tm3+→Dy3+ is [29]:

    (1)

    here, IS and IS0 are the emission intensities of Tm3+ ions when undoped and doped with Dy3+ ions, respectively. It can be visually seen from the Fig. S4(Supporting information)that the ηET value increases with the increase of Dy3+ ion concentration.When y = 0.04, the maximum ηET value is about 72.6%.

    In general, the resonant energy transfer process mainly has two types of exchange interaction and electric multipole interaction. When the exchange interaction is dominant, the critical distance between the sensitization center and the activation center should be less than 5 Å. The critical distance ( Rc) from Tm3+ to Dy3+ energy transfer can be calculated by the formula given by Blasse [30, 31]:

    (2)

    where V is the volume of the unit cell; XC is the critical concentration; N is the number of cations in the unit cell. For the BLNPF host, V = 626.735 Å3, N = 2, XC = 0.055, so the critical distance RC is determined to be 22.16 Å. Therefore, the energy transfer mechanism in this system is limited by electric multipole interaction.

    The following relationship can be obtained by analyzing the energy transfer type between the sensitizer ions Tm3+ and the activator ions Dy3+ in Dexter's multipole interaction energy transfer expression and Reisfeld approximation [32]:

    (3)

    where η0 and ηS are the luminescence quantum efficiencies of Tm3+ ions in the absence and presence of Dy3+ ions, respectively; C is the total doping concentration of Tm3+ and Dy3+ ions. When n = 6, 8, and 10, they correspond to dipole-dipole, dipole-quadrupole, and quadrupole-quadrupole interaction, respectively. The value of η0/ηS can be approximately replaced by the luminous intensity ratio IS0/IS. Fig. S5 (Supporting information) shows relationship betweenIS0/IS and C6/3, C8/3 and C10/3 of Tm3+ ions. It can be found that when n = 6, the best linear fit is obtained. The analysis shows that energy transfer from Tm3+ to Dy3+ occurs via a dipole-dipole mechanism.

    The decay curves of Ba3La0.975-yNa(PO4)3F:0.025Tm3+, yDy3+ phosphors measured at 453 nm emission with 358 nm excitation were also detected, and the decay curves are shown in Fig. S6 (Supporting information). It is found that all the decay curves can be fitted well with a second-order exponential decay, which can be obtained using the equation [33, 34]:

    (4)

    where I is the luminescence intensity, t is the time, A1 and A2 are constants, and τ1 and τ2 are rapid and slow decay times for the exponential components, respectively. According to the parameters in Eq.5, the average lifetime t* can be obtained using the formula:

    (5)

    Based on the second-order exponential function and the decay curve, Ba3La0.975-yNa(PO4)3F:0.025Tm3+, yDy3+ at 358 nm excitation. The fluorescence decay timet at 453 nm decreases with increasing Dy3+ doping concentration, and the corresponding Tm3+ fluorescence decay time τ is 7.96, 7.78, 6.56, 6.34 and 6.12ms, respectively. Therefore, the energy of Tm3+ in the co-doped sample can be transferred to Dy3+ ions.

    The emission spectrum of Ba3La0.975-yNa(PO4)3F:0.025Tm3+, yDy3+ phosphors were converted to the CIE 1931 chromaticity using the photoluminescence data and the CIE software diagram as shown in Fig. 4. It can be seen from the figure that as the concentration of Dy3+ increases, the CIE chromaticity coordinates change from (0.2830, 0.2992) to (0.3109, 0.3503), and the corresponding illuminating color gradually changes from blue to white. Obviously, by adjusting the doping concentration of Dy3+ in Ba3LaNa(PO4)3F:Tm3+, Dy3+, warm white light can be produced for different practical applications.

    Figure 4

    Figure 4.  The CIE chromaticity diagram for Ba3La0.975-yNa(PO4)3F:0.025Tm3+, yDy3+ phosphors.

    In summary, we synthesized a series of Ba3LaNa(PO4)3F:Tm3+, Dy3+ phosphors by high temperature solid phase reaction. Under the excitation of UV light, the characteristic peaks of Tm3+ and Dy3+ ions appeared in Ba3LaNa(PO4)3F: xTm3+ and Ba3LaNa(PO4)3F: yDy3+ phosphors, respectively. In addition, it is matched to commercial UV LED chips when excited at 358 nm. By fixing the Tm3+ ions concentration and changing the ions concentration of Dy3+, the luminescence color of Ba3LaNa(PO4)3F:0.025Tm3+, yDy3+ phosphor can be changed from blue to white. The analysis shows that the dipole-dipole interaction should be the reaction mechanism of the transferof energyfromTm3+toDy3+ions. These resultsindicate that Ba3LaNa(PO4)3F:Tm3+, Dy3+ may serve as a white light-emitting phosphor for white light LED.

    Supplementary material related to this article can be found, in the online version, at doi:https://doi.org/10.1016/j.cclet.2019.04.046.


    1. [1]

      M. Hoffmann, H. Kleine-Weber, S. Schroeder, et al., Cell 181 (2020) 271–280.  doi: 10.1016/j.cell.2020.02.052

    2. [2]

      M.L. Yeung, J.L.L. Teng, L. Jia, et al., Cell 184 (2021) 2212–2228.  doi: 10.1016/j.cell.2021.02.053

    3. [3]

      B. Ju, Q. Zhang, J. Ge, et al., Nature 584 (2020) 115–119.  doi: 10.1038/s41586-020-2380-z

    4. [4]

      V. Monteil, H. Kwon, P. Prado, et al., Cell 181 (2020) 905–913.  doi: 10.1016/j.cell.2020.04.004

    5. [5]

      A. Acharya, A.S. Pathania, K. Pandey, et al., Clin. Transl. Med. 12 (2022) e806.  doi: 10.1002/ctm2.806

    6. [6]

      M. Wang, H. Yan, L. Chen, et al., PLoS One 18 (2023) e0285722.  doi: 10.1371/journal.pone.0285722

    7. [7]

      A.M. Carabelli, T.P. Peacock, L.G. Thorne, et al., Nat. Rev. Microbiol. 21 (2023) 162–177.

    8. [8]

      Y. Hu, E.M. Lewandowski, H. Tan, et al., ACS Cent. Sci. 9 (2023) 1658–1669.  doi: 10.1021/acscentsci.3c00538

    9. [9]

      V.P. Chavda, R. Bezbaruah, K. Deka, et al., Vaccines 10 (2022) 1926.  doi: 10.3390/vaccines10111926

    10. [10]

      W. Chiu, L. Verschueren, C. Van den Eynde, et al., J. Med. Virol. 94 (2022) 3101–3111.  doi: 10.1002/jmv.27683

    11. [11]

      J. Liu, K. Li, L. Cheng, et al., Int. J. Infect. Dis. 103 (2021) 300–304.  doi: 10.1109/icpes53652.2021.9683843

    12. [12]

      W. Wan, S. Zhu, S. Li, et al., ACS Infect. Dis. 7 (2020) 1409–1422.

    13. [13]

      S. Yan, H. Sun, X. Bu, et al., Front. Pharmacol. 11 (2020) 548175.

    14. [14]

      J. Rout, B.C. Swain, U. Tripathy, J. Biomol. Struct. Dyn. 40 (2020) 860–874.

    15. [15]

      C. Nichols, J. Ng, A. Keshu, et al., Front. Pharmacol. 11 (2020) 615211.  doi: 10.3389/fphar.2020.615211

    16. [16]

      S.M. Chowdhury, S.A. Talukder, A.M. Khan, et al., J. Phys. Chem. B 124 (2020) 9785–9792.  doi: 10.1021/acs.jpcb.0c05621

    17. [17]

      S.J.Y. Macalino, V. Gosu, S. Hong, et al., Arch. Pharm. Res. 38 (2015) 1686–1701.  doi: 10.1007/s12272-015-0640-5

    18. [18]

      N. Okimoto, N. Futatsugi, H. Fuji, et al., PLoS Comput. Biol. 5 (2009) e1000528.  doi: 10.1371/journal.pcbi.1000528

    19. [19]

      J. Jones, R. Heim, E. Hare, et al., SLAS Discov. 5 (2000) 307–317.  doi: 10.1177/108705710000500502

    20. [20]

      G. Milligan, J. Pharm. Sci. 21 (2004) 397–405.

    21. [21]

      S.M. Rodems, B.D. Hamman, C. Lin, et al., Assay Drug Dev. Techn. 1 (2002) 9–19.  doi: 10.1089/154065802761001266

    22. [22]

      K. Gorshkov, K. Susumu, J. Chen, et al., ACS Nano 14 (2020) 12234–12247.  doi: 10.1021/acsnano.0c05975

    23. [23]

      S. Das, T. Yin, Q. Yang, et al., P. Natl. Acad. Sci. 112 (2015) 267–276.  doi: 10.11646/phytotaxa.222.4.4

    24. [24]

      J. Chen, W. Liu, X. Fang, et al., Chin. Chem. Lett. 33 (2022) 5042–5046.  doi: 10.1016/j.cclet.2022.03.120

    25. [25]

      J. Li, Q. Qiao, Y. Ruan, et al., Chin. Chem. Lett. 34 (2023) 108266.  doi: 10.1016/j.cclet.2023.10826602.003e=xml&restype=unixref&xml=|Adv. Mater.||34||2203699|2022|||

    26. [26]

      W. Liu, J. Chen, Q. Qiao, et al., Chin. Chem. Lett. 33 (2022) 4943–4947.  doi: 10.1016/j.cclet.2022.03.121

    27. [27]

      Y. Zhang, W. Zhou, N. Xu, et al., Chin. Chem. Lett. 34 (2023) 107472.  doi: 10.1016/j.cclet.2022.04.070

    28. [28]

      L. Miao, W. Zhou, C. Yan, et al., Acta Pharm. Sin. B 12 (2022) 3739–3742.  doi: 10.1016/j.apsb.2022.05.033

    29. [29]

      L. Miao, C. Yan, Y. Chen, et al., Cell Chem. Biol. 30 (2023) 248–260.  doi: 10.1016/j.chembiol.2023.02.001

    30. [30]

      J.B. Grimm, B.P. English, J. Chen, et al., Nat. Methods 12 (2015) 244–250.  doi: 10.1038/nmeth.3256

    31. [31]

      D. Si, Q. Li, Y. Bao, et al., Angew. Chem. Int. Ed. 62 (2023) e202307641.  doi: 10.1002/anie.202307641

    32. [32]

      C.U. Murade, S. Chaudhuri, I. Nabti, et al., ACS Sens. 6 (2021) 2233–2240.  doi: 10.1021/acssensors.1c00167

    33. [33]

      A.R. Braun, N.N. Kochen, S.L. Yuen, et al., ASN Neuro 15 (2023) 17590914231184086.  doi: 10.1177/17590914231184086

    34. [34]

      F. Xing, N. Ai, S. Huang, et al., Front. Bioeng. Biotech. 10 (2022) 839078.  doi: 10.3389/fbioe.2022.839078

    1. [1]

      M. Hoffmann, H. Kleine-Weber, S. Schroeder, et al., Cell 181 (2020) 271–280.  doi: 10.1016/j.cell.2020.02.052

    2. [2]

      M.L. Yeung, J.L.L. Teng, L. Jia, et al., Cell 184 (2021) 2212–2228.  doi: 10.1016/j.cell.2021.02.053

    3. [3]

      B. Ju, Q. Zhang, J. Ge, et al., Nature 584 (2020) 115–119.  doi: 10.1038/s41586-020-2380-z

    4. [4]

      V. Monteil, H. Kwon, P. Prado, et al., Cell 181 (2020) 905–913.  doi: 10.1016/j.cell.2020.04.004

    5. [5]

      A. Acharya, A.S. Pathania, K. Pandey, et al., Clin. Transl. Med. 12 (2022) e806.  doi: 10.1002/ctm2.806

    6. [6]

      M. Wang, H. Yan, L. Chen, et al., PLoS One 18 (2023) e0285722.  doi: 10.1371/journal.pone.0285722

    7. [7]

      A.M. Carabelli, T.P. Peacock, L.G. Thorne, et al., Nat. Rev. Microbiol. 21 (2023) 162–177.

    8. [8]

      Y. Hu, E.M. Lewandowski, H. Tan, et al., ACS Cent. Sci. 9 (2023) 1658–1669.  doi: 10.1021/acscentsci.3c00538

    9. [9]

      V.P. Chavda, R. Bezbaruah, K. Deka, et al., Vaccines 10 (2022) 1926.  doi: 10.3390/vaccines10111926

    10. [10]

      W. Chiu, L. Verschueren, C. Van den Eynde, et al., J. Med. Virol. 94 (2022) 3101–3111.  doi: 10.1002/jmv.27683

    11. [11]

      J. Liu, K. Li, L. Cheng, et al., Int. J. Infect. Dis. 103 (2021) 300–304.  doi: 10.1109/icpes53652.2021.9683843

    12. [12]

      W. Wan, S. Zhu, S. Li, et al., ACS Infect. Dis. 7 (2020) 1409–1422.

    13. [13]

      S. Yan, H. Sun, X. Bu, et al., Front. Pharmacol. 11 (2020) 548175.

    14. [14]

      J. Rout, B.C. Swain, U. Tripathy, J. Biomol. Struct. Dyn. 40 (2020) 860–874.

    15. [15]

      C. Nichols, J. Ng, A. Keshu, et al., Front. Pharmacol. 11 (2020) 615211.  doi: 10.3389/fphar.2020.615211

    16. [16]

      S.M. Chowdhury, S.A. Talukder, A.M. Khan, et al., J. Phys. Chem. B 124 (2020) 9785–9792.  doi: 10.1021/acs.jpcb.0c05621

    17. [17]

      S.J.Y. Macalino, V. Gosu, S. Hong, et al., Arch. Pharm. Res. 38 (2015) 1686–1701.  doi: 10.1007/s12272-015-0640-5

    18. [18]

      N. Okimoto, N. Futatsugi, H. Fuji, et al., PLoS Comput. Biol. 5 (2009) e1000528.  doi: 10.1371/journal.pcbi.1000528

    19. [19]

      J. Jones, R. Heim, E. Hare, et al., SLAS Discov. 5 (2000) 307–317.  doi: 10.1177/108705710000500502

    20. [20]

      G. Milligan, J. Pharm. Sci. 21 (2004) 397–405.

    21. [21]

      S.M. Rodems, B.D. Hamman, C. Lin, et al., Assay Drug Dev. Techn. 1 (2002) 9–19.  doi: 10.1089/154065802761001266

    22. [22]

      K. Gorshkov, K. Susumu, J. Chen, et al., ACS Nano 14 (2020) 12234–12247.  doi: 10.1021/acsnano.0c05975

    23. [23]

      S. Das, T. Yin, Q. Yang, et al., P. Natl. Acad. Sci. 112 (2015) 267–276.  doi: 10.11646/phytotaxa.222.4.4

    24. [24]

      J. Chen, W. Liu, X. Fang, et al., Chin. Chem. Lett. 33 (2022) 5042–5046.  doi: 10.1016/j.cclet.2022.03.120

    25. [25]

      J. Li, Q. Qiao, Y. Ruan, et al., Chin. Chem. Lett. 34 (2023) 108266.  doi: 10.1016/j.cclet.2023.10826602.003e=xml&restype=unixref&xml=|Adv. Mater.||34||2203699|2022|||

    26. [26]

      W. Liu, J. Chen, Q. Qiao, et al., Chin. Chem. Lett. 33 (2022) 4943–4947.  doi: 10.1016/j.cclet.2022.03.121

    27. [27]

      Y. Zhang, W. Zhou, N. Xu, et al., Chin. Chem. Lett. 34 (2023) 107472.  doi: 10.1016/j.cclet.2022.04.070

    28. [28]

      L. Miao, W. Zhou, C. Yan, et al., Acta Pharm. Sin. B 12 (2022) 3739–3742.  doi: 10.1016/j.apsb.2022.05.033

    29. [29]

      L. Miao, C. Yan, Y. Chen, et al., Cell Chem. Biol. 30 (2023) 248–260.  doi: 10.1016/j.chembiol.2023.02.001

    30. [30]

      J.B. Grimm, B.P. English, J. Chen, et al., Nat. Methods 12 (2015) 244–250.  doi: 10.1038/nmeth.3256

    31. [31]

      D. Si, Q. Li, Y. Bao, et al., Angew. Chem. Int. Ed. 62 (2023) e202307641.  doi: 10.1002/anie.202307641

    32. [32]

      C.U. Murade, S. Chaudhuri, I. Nabti, et al., ACS Sens. 6 (2021) 2233–2240.  doi: 10.1021/acssensors.1c00167

    33. [33]

      A.R. Braun, N.N. Kochen, S.L. Yuen, et al., ASN Neuro 15 (2023) 17590914231184086.  doi: 10.1177/17590914231184086

    34. [34]

      F. Xing, N. Ai, S. Huang, et al., Front. Bioeng. Biotech. 10 (2022) 839078.  doi: 10.3389/fbioe.2022.839078

  • 加载中
    1. [1]

      Yang LiNing ShengKun WangYuhuan LiJiandong JiangJinlan Zhang . Azvudine alleviates SARS-CoV-2-induced inflammation by targeting myeloperoxidase in NETosis. Chinese Chemical Letters, 2025, 36(5): 110238-. doi: 10.1016/j.cclet.2024.110238

    2. [2]

      Yulong ShiFenbei ChenMengyuan WuXin ZhangRunze MengKun WangYan WangYuheng MeiQionglu DuanYinghong LiRongmei GaoYuhuan LiHongbin DengJiandong JiangYanxiang WangDanqing Song . Chemical construction and anti-HCoV-OC43 evaluation of novel 10,12-disubstituted aloperine derivatives as dual cofactor inhibitors of TMPRSS2 and SR-B1. Chinese Chemical Letters, 2024, 35(5): 108792-. doi: 10.1016/j.cclet.2023.108792

    3. [3]

      Zhichao ZhouFuqian ChenXiaotong XiaDong YeRong ZhouLei LiTao DengZhenhua DingFang Liu . Developing a fluorescence substrate for HRP-based diagnostic assays with superiorities over the commercial ADHP. Chinese Chemical Letters, 2024, 35(6): 108970-. doi: 10.1016/j.cclet.2023.108970

    4. [4]

      Zhexin ChenYuqing ShiFang ZhongKai ZhangFurong ZhangShenghong XieZhongbin ChengQian ZhouYi-You HuangHai-Bin Luo . Discovery of amentoflavone as a natural PDE4 inhibitor with anti-fibrotic effects. Chinese Chemical Letters, 2025, 36(4): 109956-. doi: 10.1016/j.cclet.2024.109956

    5. [5]

      Zhiqiang LiuQiang GaoWei ShenMeifeng XuYunxin LiWeilin HouHai-Wei ShiYaozuo YuanErwin AdamsHian Kee LeeSheng Tang . Removal and fluorescence detection of antibiotics from wastewater by layered double oxides/metal-organic frameworks with different topological configurations. Chinese Chemical Letters, 2024, 35(8): 109338-. doi: 10.1016/j.cclet.2023.109338

    6. [6]

      Yuxin LiChengbin LiuQiuju LiShun Mao . Fluorescence analysis of antibiotics and antibiotic-resistance genes in the environment: A mini review. Chinese Chemical Letters, 2024, 35(10): 109541-. doi: 10.1016/j.cclet.2024.109541

    7. [7]

      Gengchen GuoTianyu ZhaoRuichang SunMingzhe SongHongyu LiuSen WangJingwen LiJingbin Zeng . Au-Fe3O4 dumbbell-like nanoparticles based lateral flow immunoassay for colorimetric and photothermal dual-mode detection of SARS-CoV-2 spike protein. Chinese Chemical Letters, 2024, 35(6): 109198-. doi: 10.1016/j.cclet.2023.109198

    8. [8]

      Yunxin LiJinghui ZhangJisen ChenFeng ZhuZhiqiang LiuPeng BaoWei ShenSheng Tang . Detection of SARS-CoV-2 based on artificial intelligence-assisted smartphone: A review. Chinese Chemical Letters, 2024, 35(7): 109220-. doi: 10.1016/j.cclet.2023.109220

    9. [9]

      Xiaoyao MaJinling ZhangGe FangHe GaoJie GaoLi FuYuanyuan HouGang Bai . Förster resonance energy transfer reveals phillygenin and swertiamarin concurrently target AKT on different binding domains to increase the anti-inflammatory effect. Chinese Chemical Letters, 2024, 35(5): 108823-. doi: 10.1016/j.cclet.2023.108823

    10. [10]

      Mengxing LiuJing LiuHongxing ZhangJianan TaoPeiwen FanXin LvWei Guo . One-pot accessing of meso–aryl heptamethine indocyanine NIR fluorophores and potential application in developing dye-antibody conjugate for imaging tumor. Chinese Chemical Letters, 2025, 36(4): 109994-. doi: 10.1016/j.cclet.2024.109994

    11. [11]

      Han YuanFengcai ZhangHongzhe HuangJiafei WuYi YangWanyi HuangDongjing YangZhuoming LiZhe LiLing HuangYi-You HuangHai-Bin LuoLei Guo . Discovery of 3-trifluoromethyl-substituted pyrazoles as selective phosphodiesterase 10A inhibitors for orally attenuating isoprenaline-induced cardiac hypertrophy. Chinese Chemical Letters, 2025, 36(4): 109965-. doi: 10.1016/j.cclet.2024.109965

    12. [12]

      Jia ChenYun LiuZerong LongYan LiHongdeng Qiu . Colorimetric detection of α-glucosidase activity using Ni-CeO2 nanorods and its application to potential natural inhibitor screening. Chinese Chemical Letters, 2024, 35(9): 109463-. doi: 10.1016/j.cclet.2023.109463

    13. [13]

      Shuheng ZhangYuanyuan ZhangWanyu WangYuzhu HuXinchuan ChenBilan WangXiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658

    14. [14]

      Meirong HANXiaoyang WEISisi FENGYuting BAI . A zinc-based metal-organic framework for fluorescence detection of trace Cu2+. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1603-1614. doi: 10.11862/CJIC.20240150

    15. [15]

      Xuehua SUNMin MAJianting LIURui TIANHongmei CHAIHuali CUILoujun GAO . Pr/N co-doped biomass carbon dots with enhanced fluorescence for efficient detection of 2,4-dinitrophenylhydrazine. Chinese Journal of Inorganic Chemistry, 2025, 41(3): 561-573. doi: 10.11862/CJIC.20240294

    16. [16]

      Yiling LiZekun GaoXiuxiu YueMinhuan LanXiuli ZhengBenhua WangShuang ZhaoXiangzhi Song . FRET-based two-photon benzo[a] phenothiazinium photosensitizer for fluorescence imaging-guided photodynamic therapy. Chinese Chemical Letters, 2024, 35(7): 109133-. doi: 10.1016/j.cclet.2023.109133

    17. [17]

      Linfang ZHANGWenzhu YINGui YIN . A 2-dicyanomethylene-3-cyano-4,5,5-trimethyl-2,5-dihydrofuran-based near-infrared fluorescence probe for the detection of hydrogen sulfide and imaging of living cells. Chinese Journal of Inorganic Chemistry, 2025, 41(3): 540-548. doi: 10.11862/CJIC.20240405

    18. [18]

      Chun-Lin Sun Yaole Jiang Yu Chen Rongjing Guo Yongwen Shen Xinping Hui Baoxin Zhang Xiaobo Pan . Construction, Performance Testing, and Practical Applications of a Home-Made Open Fluorescence Spectrometer. University Chemistry, 2024, 39(5): 287-295. doi: 10.3866/PKU.DXHX202311096

    19. [19]

      Ying LiLong-Jie WangYong-Kang ZhouJun LiangBin XiaoJi-Shen Zheng . An improved installation of 2-hydroxy-4-methoxybenzyl (iHmb) method for chemical protein synthesis. Chinese Chemical Letters, 2024, 35(5): 109033-. doi: 10.1016/j.cclet.2023.109033

    20. [20]

      Bo LiuShuaiqiang ShaoJunjie CaiZijian ZhangFeng TianKun YangFan Li . Signal cascade amplification of streptavidin-biotin-modified immunofluorescence nanocapsules for ultrasensitive detection of glial fibrillary acidic protein. Chinese Chemical Letters, 2025, 36(3): 109814-. doi: 10.1016/j.cclet.2024.109814

Metrics
  • PDF Downloads(3)
  • Abstract views(581)
  • HTML views(13)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return